Pursuit of Sinus Rhythm in Patients with Atrial Fibrillation: Is the Effort Worth It?

Wattigney WA , Mensah GA , Croft JB . Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: Implications for primary prevention. Circulation 108:711-716, 2003

Go AS , Hylek EM , Phillips KA , et al . Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention. The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370-2375, 2001

Tsang TS , Gersh BJ . Atrial fibrillation: An old disease, a new epidemic. Am J Med 113:432-435, 2002

Nattel S . New ideas about atrial fibrillation 50 years on. Nature 415:219-226, 2002

Prystowsky EN , Benson DW Jr , Woodrow M , et al . Management of patients with atrial fibrillation: A statement of healthcare professionals from Subcommittee on Electrocardiography and Electrophysiology. American Heart Association. Circulation 93(6):1262-1277, 1996

Benjamin EJ , Wolf PA , D’Agostino RB , et al . Impact of atrial fibrillation on the risk of death. The Framingham Study. Circulation 98:946-952, 1998

The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators . A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:185-194, 2002

Singh BN . Atrial Fibrillation Following Investigation of Rhythm Management: AFFIRM Trial Outcomes. What might be their implications for arrhythmia control? J Cardiovasc Pharmacol Therapeut 7:131-133, 2002

Vora A , Karnad D , Goyal V , et al . Control of heart rate versus rhythm in rheumatic atrial fibrillation: A randomized study. J Cardiovasc Pharmacol Therapeut 9(2)65:73, 2004

Dorian P , Mangat I , Pinter A , et al . The burden of atrial fibrillation: Should we abandon antiarrhythmic drug therapy? J Cardiovasc Pharmacol Therapeut (in press, this issue, 2004)

Dorian P , Jung W , Newman D , et al . The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment for investigational therapy. J Am Coll Cardiol 36:1303-1309, 2000

Paquette M , Roy D , Talazic M , et al . Role of gender and personality and quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol 86:764-768, 2000

Hagens VE , Ranchor AV , Sonderen EV , et al for the RACE Study Group . Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. J Am Coll Cardiol 43:241-247, 2004

Dorian P , Paquette M , Newman D , et al for the CTAF Investigators Toronto, Ottawa and Hamilton, Ontario and Montreal, Quebec, Canada . Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 143:984-990, 2002

Van Gelder IC , Crijns HJ , Blanksma PK , et al . Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 72:560-566, 1993

Ueshima K , Myers J , Morris CK , et al . The effect of cardioversion on exercise capacity in patients with atrial fibrillation. Am Heart J 126:1021-1024, 1993

Singh BN . Atrial fibrillation: Epidemiologic considerations and rationale for conversion and maintenance of sinus rhythm. J Cardiovasc Pharmacol Therapeut 8(1):S13-S26, 2003

Singh BN . Current antiarrhythmic drugs: An overview of mechanisms of action and potential clinical utility. J Cardiovasc Electrophysiol 10:283-301, 1999